Carla Jiménez-Jiménez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Carla Jiménez-Jiménez has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- María Vallet-Regí
Universidad Complutense de Madrid
3 shared publications - Aránzazu Mediero
Joint and Bone Research Unit, Fundación Instituto de Investigación Sanitaria‐Fundación Jiménez Díaz Universidad Autónoma de Madrid Madrid Spain
1 shared publication - Jaime Esteban
Department of Clinical Microbiology, IIS-Fundación Jiménez Díaz, UAM, Madrid, Spain
1 shared publication - John Jairo Aguilera-Correa
Clinical Microbiology Department, IIS-Fundación Jiménez Díaz, Universidad Autónoma de Madrid, 28040 Madrid, Spain
1 shared publication - Miguel Gisbert-Garzarán
Departamento de Química y Ciencias Farmacéuticas, Unidad de Química Inorgánica y Bioinorgánica, Facultad de Farmacia, Universidad Complutense, Madrid, Spain
1 shared publication - Miguel Manzano
Dpto. Química en Ciencias Farmacéuticas, U.D Química Inorgánica y Bioinorgánica. Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Hospital, 12 de Octubre i+12, Plaza Ramón y Cajal s/n, Madrid, 28040, Spain
1 shared publication
Latest Publications
- Open Access
- 17 January 2022
- Published by MDPI AG in Nanomaterials
- Vol. 12 (2) , 288
Bacteria-Assisted Transport of Nanomaterials to Improve Drug Delivery in Cancer Therapy
Currently, the design of nanomaterials for the treatment of different pathologies is presenting a major impact on biomedical research. Thanks to this, nanoparticles represent a successful strategy for the delivery of high amounts of drugs for the treatment of cancer. Different nanosystems have been designed to combat this pathology. However, the poor penetration of these nanomaterials into the tumor tissue prevents the drug from entering the inner regions of the tumor. Some bacterial strains have self-propulsion and guiding capacity thanks to their flagella. They also have a preference to accumulate in certain tumor regions due to the presence of different chemo-attractants factors. Bioconjugation reactions allow the binding of nanoparticles in living systems, such as cells or bacteria, in a simple way. Therefore, bacteria are being used as a transport vehicle for nanoparticles, facilitating their penetration and the subsequent release of the drug inside the tumor. This review would summarize the literature on the anchoring methods of diverse nanosystems in bacteria and, interestingly, their advantages and possible applications in cancer therapy.
- 17 January 2022
- Published by MDPI AG in Nanomaterials
- Vol. 12 (2) , 288
Open AccessBacteria-Assisted Transport of Nanomaterials to Improve Drug Delivery in Cancer Therapy
Currently, the design of nanomaterials for the treatment of different pathologies is presenting a major impact on biomedical research. Thanks to this, nanoparticles represent a successful strategy for the delivery of high amounts of drugs for the treatment of cancer. Different nanosystems have been designed to combat this pathology. However, the poor penetration of these nanomaterials into the tumor tissue prevents the drug from entering the inner regions of the tumor. Some bacterial strains have self-propulsion and guiding capacity thanks to their flagella. They also have a preference to accumulate in certain tumor regions due to the presence of different chemo-attractants factors. Bioconjugation reactions allow the binding of nanoparticles in living systems, such as cells or bacteria, in a simple way. Therefore, bacteria are being used as a transport vehicle for nanoparticles, facilitating their penetration and the subsequent release of the drug inside the tumor. This review would summarize the literature on the anchoring methods of diverse nanosystems in bacteria and, interestingly, their advantages and possible applications in cancer therapy.
- Open Access
- 1 January 2022
- Published by Elsevier in Acta Biomaterialia
- Vol. 137, 218-237
Arabic gum plus colistin coated moxifloxacin-loaded nanoparticles for the treatment of bone infection caused by Escherichia coli
- 1 January 2022
- Published by Elsevier in Acta Biomaterialia
- Vol. 137, 218-237
Open AccessArabic gum plus colistin coated moxifloxacin-loaded nanoparticles for the treatment of bone infection caused by Escherichia coli
- Open Access
Nanoparticles Coated with Cell Membranes for Biomedical Applications
Nanoparticles designed for diagnosing and treating different diseases have impacted the scientific research in biomedicine, and are expected to revolutionize the clinic in the near future through a new area called nanomedicine. In the last few years, a new approach in this field has emerged: the use of cell membranes for coating nanoparticles in an attempt to mimic the ability of cells to interface and interact with physiological environments. Although such functions have been replicated through synthetic techniques, many research groups are now employing naturally derived cell membranes to coat different types of nanoparticles in an attempt to improve their performance for a wide range of applications. This review summarizes the literature on nanoparticles coated with cell membranes and, more importantly, aims at inspiring and encouraging new developments to this technology in the biomedical area.
Open AccessNanoparticles Coated with Cell Membranes for Biomedical Applications
Nanoparticles designed for diagnosing and treating different diseases have impacted the scientific research in biomedicine, and are expected to revolutionize the clinic in the near future through a new area called nanomedicine. In the last few years, a new approach in this field has emerged: the use of cell membranes for coating nanoparticles in an attempt to mimic the ability of cells to interface and interact with physiological environments. Although such functions have been replicated through synthetic techniques, many research groups are now employing naturally derived cell membranes to coat different types of nanoparticles in an attempt to improve their performance for a wide range of applications. This review summarizes the literature on nanoparticles coated with cell membranes and, more importantly, aims at inspiring and encouraging new developments to this technology in the biomedical area.